Back to Journals » OncoTargets and Therapy » Volume 9

Patients harboring EGFR mutation after primary resistance to crizotinib and response to EGFR-tyrosine kinase inhibitor

Total article views   HTML views PDF downloads Totals
8,012 Dovepress* 7,347+ 1,379 8,726
PubMed Central* 665 251 916
Totals 8,012 1,630 9,642
*Since 8 January 2016
+Since July 2016

View citations on PubMed Central and Google Scholar